Table 2 Medication at admission
Medications 24 h | Male | Female | Total | P value |
|---|---|---|---|---|
Aspirin | 592 (99.00%) | 163 (99.39%) | 755 (99.08%) | 0.640 |
Clopidogrel | 533 (89.13%) | 154 (93.90%) | 687 (90.16%) | 0.069 |
Prasugrel | 3 (0.50%) | 0 (0.00%) | 3 (0.39%) | 0.363 |
Ticagrelor | 59 (9.87%) | 5 (3.05%) | 64 (8.40%) | 0.005 |
Beta blockers | 531 (88.80%) | 130 (79.27%) | 661 (86.75%) | 0.001 |
ACEI/ARB | 462 (77.26%) | 132 (80.49%) | 594 (77.95%) | 0.377 |
Statins | 570 (95.32%) | 159 (96.95%) | 729 (95.67%) | 0.363 |
Aldosterone inhibitor (spironolactone) | 54 (9.03%) | 18 (10.98%) | 72 (9.45%) | 0.451 |
Heparins UH/LMWH | 552 (92.31%) | 148 (90.24%) | 700 (91.86%) | 0.392 |
GP_2b3a_inhibitors | 97 (16.22%) | 15 (9.15%) | 112 (14.70%) | 0.023 |
Insulin | 284 (47.49%) | 114 (69.51%) | 398 (52.23%) | < .001 |
Oral hp agents | 74 (12.37%) | 32 (19.51%) | 106 (13.91%) | 0.019 |